Other OTC Pharmaceuticals (Pharmacies) - Guyana

  • Guyana
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$4.43m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.91%, resulting in a market volume of US$4.87m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$5.40 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Guyana is experiencing steady growth due to various factors such as increasing customer preferences for self-medication, rising awareness about OTC products, and favorable local special circumstances. Additionally, underlying macroeconomic factors such as population growth and urbanization are also contributing to the development of the market.

Customer preferences:
Customers in Guyana are increasingly opting for over-the-counter (OTC) pharmaceuticals for self-medication purposes. This preference can be attributed to the convenience and accessibility of OTC products, which can be purchased directly from pharmacies without a prescription. Moreover, customers are becoming more aware of the benefits of OTC medications, such as cost-effectiveness and the ability to treat minor ailments without visiting a healthcare professional.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals (Pharmacies) market in Guyana is the growing demand for vitamins and dietary supplements. Customers are becoming more health-conscious and are seeking preventive measures to maintain their well-being. This trend is driving the sales of OTC vitamins and dietary supplements in pharmacies across the country. Another trend observed in the market is the increasing popularity of herbal and natural remedies. Customers are showing a preference for alternative medicine and are seeking products with natural ingredients. This trend is driving the demand for herbal and natural OTC pharmaceuticals in Guyana.

Local special circumstances:
The healthcare infrastructure in Guyana is still developing, with limited access to healthcare facilities in some remote areas. As a result, pharmacies play a crucial role in providing healthcare services and medications to the population. The availability of OTC pharmaceuticals in pharmacies allows customers to access essential medications without the need for a prescription, bridging the gap in healthcare services.

Underlying macroeconomic factors:
Population growth and urbanization are key macroeconomic factors driving the development of the Other OTC Pharmaceuticals (Pharmacies) market in Guyana. The country's population is increasing, leading to a larger customer base for OTC pharmaceuticals. Additionally, urbanization is resulting in higher disposable incomes and increased access to healthcare services, further fueling the demand for OTC products. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Guyana is witnessing growth due to customer preferences for self-medication, increasing awareness about OTC products, and favorable local special circumstances. The market is also influenced by underlying macroeconomic factors such as population growth and urbanization. As the market continues to evolve, it is expected that the demand for OTC pharmaceuticals, particularly vitamins, dietary supplements, and herbal remedies, will continue to increase in Guyana.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)